| NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ... Nature communications 6 (1), 6170, 2015 | 301 | 2015 |
| Histone variants: emerging players in cancer biology C Vardabasso, D Hasson, K Ratnakumar, CY Chung, LF Duarte, ... Cellular and molecular life sciences 71, 379-404, 2014 | 201 | 2014 |
| Histone variant H2A. Z. 2 mediates proliferation and drug sensitivity of malignant melanoma C Vardabasso, A Gaspar-Maia, D Hasson, S Pünzeler, D Valle-Garcia, ... Molecular cell 59 (1), 75-88, 2015 | 197 | 2015 |
| Sox2 in the dermal papilla niche controls hair growth by fine-tuning BMP signaling in differentiating hair shaft progenitors C Clavel, L Grisanti, R Zemla, A Rezza, R Barros, R Sennett, AR Mazloom, ... Developmental cell 23 (5), 981-994, 2012 | 163 | 2012 |
| Single-cell transcriptomes distinguish stem cell state changes and lineage specification programs in early mammary gland development RR Giraddi, CY Chung, RE Heinz, O Balcioglu, M Novotny, CL Trejo, ... Cell reports 24 (6), 1653-1666. e7, 2018 | 141 | 2018 |
| Epigenetic and transcriptomic profiling of mammary gland development and tumor models disclose regulators of cell state plasticity C Dravis, CY Chung, NK Lytle, J Herrera-Valdez, G Luna, CL Trejo, ... Cancer cell 34 (3), 466-482. e6, 2018 | 131 | 2018 |
| Cbx8 acts non-canonically with Wdr5 to promote mammary tumorigenesis CY Chung, Z Sun, G Mullokandov, A Bosch, ZA Qadeer, E Cihan, Z Rapp, ... Cell reports 16 (2), 472-486, 2016 | 105 | 2016 |
| Single-cell chromatin analysis of mammary gland development reveals cell-state transcriptional regulators and lineage relationships CY Chung, Z Ma, C Dravis, S Preissl, O Poirion, G Luna, X Hou, ... Cell reports 29 (2), 495-510. e6, 2019 | 82 | 2019 |
| BMP4 sufficiency to induce choroid plexus epithelial fate from embryonic stem cell-derived neuroepithelial progenitors M Watanabe, YJ Kang, LM Davies, S Meghpara, K Lau, CY Chung, ... Journal of Neuroscience 32 (45), 15934-15945, 2012 | 82 | 2012 |
| Tuft cells inhibit pancreatic tumorigenesis in mice by producing prostaglandin D2 KE DelGiorno, CY Chung, V Vavinskaya, HC Maurer, SW Novak, NK Lytle, ... Gastroenterology 159 (5), 1866-1881. e8, 2020 | 49 | 2020 |
| Tuft cell formation reflects epithelial plasticity in pancreatic injury: implications for modeling human pancreatitis KE DelGiorno, RF Naeem, L Fang, CY Chung, C Ramos, N Luhtala, ... Frontiers in physiology 11, 88, 2020 | 46 | 2020 |
| Stem cell determinant SOX9 promotes lineage plasticity and progression in basal-like breast cancer JR Christin, C Wang, CY Chung, Y Liu, C Dravis, W Tang, MH Oktay, ... Cell reports 31 (10), 2020 | 42 | 2020 |
| SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance K Jensen-Pergakes, J Tatlock, KA Maegley, IJ McAlpine, M McTigue, ... Molecular cancer therapeutics 21 (1), 3-15, 2022 | 35 | 2022 |
| Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer N Bansal, K Petrie, R Christova, CY Chung, BA Leibovitch, L Howell, V Gil, ... Oncotarget 6 (33), 34087, 2015 | 33 | 2015 |
| Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4‐driven transcriptional state W Yan, CY Chung, T Xie, M Ozeck, TC Nichols, J Frey, AR Udyavar, ... Molecular Oncology 16 (6), 1309-1328, 2022 | 18 | 2022 |
| Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells YJ Kwon, BA Leibovitch, N Bansal, L Pereira, CY Chung, EV Ariztia, ... Oncotarget 8 (51), 88421, 2017 | 18 | 2017 |
| Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer S Sharma, CY Chung, S Uryu, J Petrovic, J Cao, A Rickard, N Nady, ... Cell Chemical Biology 30 (10), 1191-1210. e20, 2023 | 8 | 2023 |
| MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming W Mohammed Ismail, A Mazzone, FG Ghiraldini, J Kaur, M Bains, ... Communications Biology 6 (1), 215, 2023 | 7 | 2023 |
| NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes. Nat Commun. 2015; 6: 6170 MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ... | 7 | |
| PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib X Ding, Z Zhu, J Lapek, EA McMillan, A Zhang, CY Chung, S Dubbury, ... Scientific Reports 12 (1), 12501, 2022 | 4 | 2022 |
